Literature DB >> 2908700

Effect of propranolol on ventricular repolarization and refractoriness: role of beta-blockade versus direct membrane effects.

D E Euler1, P J Scanlon.   

Abstract

The purpose of this study was to define the role of beta-adrenergic blockade and direct membrane effects in the ability of dl-propranolol to alter ventricular repolarization and refractoriness in the intact heart. The effective refractory period (ERP) and the local Q-T interval were measured at an epicardial site in the left ventricle in 14 open-chest dogs anesthetized with alpha-chloralose. Beta-adrenergic influences were eliminated in seven dogs (group 1) by stellate transection and nadolol (0.5 mg/kg IV), and enhanced in seven dogs (group 2) by stellate transection and stimulation of the left ansae subclavia. Each dog received an initial beta-blocking dose of propranolol (0.5 mg/kg) followed by a second, cumulative dose of 5.0 mg/kg. In group 1 dogs, there was no significant change in either the ERP or local Q-T interval in response to the first dose of propranolol. In group 2 dogs, left stellate stimulation significantly shortened the ERP (20 +/- 2 msec) and the local Q-T interval (17 +/- 4 msec). The first dose of propranolol prolonged these parameters to values not different from prestimulation control values. There was no change in the H-V interval, QRS complex duration, or diastolic threshold (DT) in either group after the initial propranolol dose. The second dose of propranolol significantly shortened the ERP (5 +/- 1 msec) and the local Q-T interval (11 +/- 2 msec) in both groups. This dose also significantly increased the DT, H-V interval, and QRS complex duration.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2908700     DOI: 10.1007/BF02125746

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  27 in total

1.  EFFECTS OF CARDIAC SYMPATHETIC NERVE STIMULATION ON CONDUCTION IN THE HEART.

Authors:  A G WALLACE; S J SARNOFF
Journal:  Circ Res       Date:  1964-01       Impact factor: 17.367

2.  Pharmacology of nadolol (SQ 11725), a beta-adrenergic antagonist lacking direct myocardial depression.

Authors:  R J Lee; D B Evans; S H Baky; R J Laffan
Journal:  Eur J Pharmacol       Date:  1975 Sep-Oct       Impact factor: 4.432

3.  Studies on the absorption, distribution and excretion of propranolol in rat, dog and monkey.

Authors:  A Hayes; R G Cooper
Journal:  J Pharmacol Exp Ther       Date:  1971-02       Impact factor: 4.030

4.  Beta-adrenergic blockade and atrio--ventricular conduction impairment.

Authors:  J F Giudicelli; F Lhoste; J R Boissier
Journal:  Eur J Pharmacol       Date:  1975-04       Impact factor: 4.432

5.  Functional distribution of the peripheral cardiac sympathetic pathways.

Authors:  M N Levy; M L Ng; H Zieske
Journal:  Circ Res       Date:  1966-09       Impact factor: 17.367

6.  A comparison of the effects of (plus of minus)-propranolol and (plus)-propranolol in anaesthetized dogs; beta-receptor blocking and haemodynamic action.

Authors:  A M Barrett
Journal:  J Pharm Pharmacol       Date:  1969-04       Impact factor: 3.765

7.  Effects of concentration and steric configuration of propranolol on AV conduction and ventricular repolarization in the dog.

Authors:  L Brorson; S Reele; W Dupont; R Woosley; D Shand; R Smith
Journal:  J Cardiovasc Pharmacol       Date:  1981 Jul-Aug       Impact factor: 3.105

8.  Antifibrillatory properties of the beta-adrenergic receptor antagonists, nadolol, sotalol, atenolol and propranolol, in the anesthetized dog.

Authors:  E Patterson; B R Lucchesi
Journal:  Pharmacology       Date:  1984       Impact factor: 2.547

9.  Distribution of local repolarization changes produced by efferent vagal stimulation in the canine ventricles.

Authors:  J B Martins; D P Zipes; D D Lund
Journal:  J Am Coll Cardiol       Date:  1983-12       Impact factor: 24.094

10.  Prolonged ventricular refractoriness and action potential duration after beta-adrenoreceptor blockade in the dog heart in situ.

Authors:  J P Amlie; H Refsum; K H Landmark
Journal:  J Cardiovasc Pharmacol       Date:  1982 Jan-Feb       Impact factor: 3.105

View more
  1 in total

1.  Cardiac effects of chronic oral beta-blockade: lack of agreement between heart rate and QT interval changes.

Authors:  Fabrice Extramiana; Pierre Maison-Blanche; René Tavernier; Luc Jordaens; Antoine Leenhardt; Philippe Coumel
Journal:  Ann Noninvasive Electrocardiol       Date:  2002-10       Impact factor: 1.468

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.